Lupin's generic drug to treat ADHD symptoms gets USFDA approval Farhat Nasim20 Nov 2024 2:57 PM ISTMumbai: Lupin Limited announced on Tuesday that it has received approval from the United States Food and Drug Administration (U.S. FDA) for its...
Lupin names Claus Jepsen as President, Global Specialty MD Bureau21 Oct 2024 6:22 PM ISTClaus joins Lupin from Takeda Pharmaceuticals, where he led the Global Strategy for Rare Diseases.
Mezagitamab Delivers Strong Platelet Response and Safety Profile in Immune Thrombocytopenia Treatment: Study Medha Baranwal29 Jun 2024 9:45 AM ISTUSA: Promising findings from the Phase 2b TAK-079-1004 study have been unveiled by Takeda Pharmaceuticals at the 32nd Congress of the International...
Medical Bulletin 13/December/2022 Isra Zaman13 Dec 2022 1:03 PM ISTHere are the top medical news for the day:Extreme temperatures linked to cardiovascular deathsAmong the cardiovascular diseases examined in a recent...
Modakafusp alfa shows promise in treating multiple myeloma, study finds Isra Zaman13 Dec 2022 9:00 AM ISTAccording to the American Cancer Society, about 12,640 deaths from multiple myeloma are expected to occur in the U.S. in 2022. The cancer is...
Alembic Pharma gets tentative USFDA approval for depressive disorder drug Medical Dialogues Bureau10 Jan 2022 2:30 PM ISTNew Delhi: Alembic Pharmaceuticals Ltd on Friday said it has received tentative approval from the US health regulator for its generic Vortioxetine...
